🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective, single-arm, open-label clinical trial is to e...
Status
Not Yet Recruiting
Location
Huashan Hospital
Start Date
2026-04-01
Trial ID
NCT07469735
The purpose of this study is to determine the safety and efficacy of a PEPI...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2025-07-15
Trial ID
NCT05609994
Treatments Being Tested
The objective of this study is to evaluate the pharmacokinetics, safety, an...
Status
Recruiting
Location
Arizona Clinical Trials
Start Date
2026-04-23
Trial ID
NCT07250633
Treatments Being Tested
The goal of this prospective, observational study VIOLETA is to collect rea...
Status
Recruiting
Location
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Start Date
2025-12-08
Trial ID
NCT07240662
Treatments Being Tested
Vorasidenib in combination with pembrolizumab in participants with recurren...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-01-20
Trial ID
NCT05484622
Treatments Being Tested
The objective of this study is to evaluate the effect of multiple doses of ...
Status
Completed
Location
Celerion
Start Date
2025-10-07
Trial ID
NCT07235748
Treatments Being Tested
The goal of this Study is to evaluate the effectiveness and safety of Voras...
Status
Active Not Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2025-09-02
Trial ID
NCT06969352
Treatments Being Tested
The objective of this study is to evaluate the effect of multiple oral dose...
Status
Completed
Location
Celerion
Start Date
2025-11-05
Trial ID
NCT07235774
Treatments Being Tested
Study AG881-C-004 is a phase 3, multicenter, randomized, double-blind, plac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-01-05
Trial ID
NCT04164901
Treatments Being Tested
This study will test the hypothesis that vorasidenib in combination with lo...
Status
Not Yet Recruiting
Location
UMPC Hillman Cancer Center
Start Date
2026-06-30
Trial ID
NCT07629089
Treatments Being Tested